PeptideStack
5.2kquestions
20kanswers
220users

What does a quantified content assay add for liraglutide that a purity figure does not?

Asked 14 Mar 2024Modified 2.1 years agoViewed 26k times
23

The case in front of me: a quantified content assay · liraglutide.

I would like the axes of comparison first and the recommendation second.

I have tried the first option and it works; the question is whether the second is better rather than merely different.

What is the actual trade-off, and does it matter at the scale I am working at?

content-assay
content-assay

Quantified content: how many milligrams of peptide are actually in the vial, measured against a calibrated reference standard. A separate test…

438 questions
purity
purity

Purity as chromatographic area per cent - the fraction of detected material that is your target peak. It says nothing about how much material is…

788 questions
coa
coa

Certificates of analysis: what fields a useful one carries, how to tell a real analytical report from a marketing document, batch and lot…

749 questions
shareeditfollowflag
CC
askedcake_collapsed13k2814 Mar 2024

4 Answers

Accepted answer first, then by votes
102

Accepted answer

The part that matters: most research-grade certificates report purity without content, which is exactly backwards from what users actually need.

A content assay is always paired with a purity assay because purity tells you what fraction of the measured mass is the target and content tells you the total measured mass.

Mass shifts and what they usually mean

Δ mass (Da)Most likely causeDistinguishing feature
+1Deamidation (Asn or Gln)New peak, slightly earlier retention
−17Loss of ammoniaOften with deamidation
−18Dehydration / succinimidepH-dependent, reversible
+16Oxidation (Met, Trp)Earlier retention, light-related
−128Missing Gln or LysDeletion sequence from synthesis
0Isomer: racemisation or scramblingSame mass, shifted retention

If a sample shows high purity but low content, the explanation is usually that the standard used for quantitation had a different purity than claimed.

Pharmacopoeial guidance on quantitative methods specifies validation steps for linearity, range, accuracy and precision that most research-grade work does not claim to meet.

Worth noting that the standard certificate carries its own uncertainty, usually on the order of two to three per cent, which the sample result inherits.

Ask for both the purity and the content, and do not accept purity alone.

shareimprove this answerflag
LT
answered · acceptedlane_transit42k3827 May 2024
Sponsored

Sigma-Aldrich - Certified Reference Materials

Analytical standards and reagents with traceable certificates. Every quantitative result you read inherits the accuracy of the standard behind it.

Shop standards
39

Specifically, content assay and purity are orthogonal measurements answering orthogonal questions, and the confusion between them is one of the most expensive misreadings in this space.

If the standard and sample have different absorption coefficients at the detection wavelength, the response factors differ and the inference fails.

Stated carefully, quantitation against a certified reference material assumes the sample and standard are treated identically through the analytical method, which is why the method for calibration matters as much as the method for measurement.

Quantitation against a standard requires that the standard be traceable to a national metrology institute, and certificates for research-grade standards claim that traceability.

The limitation is that a quantitative method is only as good as the standard it uses, and a cheap standard is a false economy.

If a supplier gives you content without the standard's purity, ask them to provide it.

shareimprove this answerflag
MO
answeredmarta_okonkwo87k2587 Jun 2024
5Worth adding that the method section is where the answer usually is. – h_villanueva 3 months ago
add a comment
29

The relevant detail is that reading a content result requires knowing the purity of the standard against which the sample was quantified, because your result inherits that uncertainty.

The purity of the reference standard is stated on its certificate, and your content figure is only as good as that purity certificate is.

Specifically, running multiple independent aliquots of the same sample should give results that agree to within the method precision, which is usually one to three per cent.

The relative standard deviation on replicate quantitations of a homogeneous sample should be below two per cent when the method is under control.

I would not rely on a content figure from a lab that is not willing to state their standard's purity on request.

The practical summary: if you are ordering from a new supplier, budget for content assay on the first lot.

shareimprove this answerflag
TU
answeredtenth_of_a_unit40k385 May 2024
8This matches what I was told by a laboratory, for whatever that is worth. – forty_two_c 3 months ago
Minor: the trial name is hyphenated in the original publication. – Dr_Tomas_Kral 4 months ago
add a comment
22

Content assay requires a reference standard of known purity and traceability, which is why it costs more than purity testing does.

The single most common reason for disagreement between a supplier content figure and an independent assay is using different standards.

Where content data have been published from testing services on common peptides, the spread between services on identical material is typically a few per cent.

The caveat is that content assay costs more than purity, so most people do not do it, which is exactly why it is valuable on the first lot from a new supplier.

Ask for both the purity and the content, and do not accept purity alone.

edited 25 May 2024 by Dr_Hanne_Solberg — clarified the distinction between purity and content

shareimprove this answerflag
DS
answeredDr_Hanne_Solberg40k3816 May 2024

Your answer

Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.

Not medical advice. Research-use-only compounds are not approved for human use.